NEWS

For our visitors who seek the latest industry news and updates to keep abreast with the goings-on of the business on a global scale, Pharmaceutical Industry portal grants a dynamic and diverse feed of news items.

news

Gilead Sciences Inc may have scored a dramatic and unexpected win over Merck & Co earlier this month in a patent dispute over the world's best-selling hepatitis C cure, but the war over this highly lucrative class of treatments has only just begun. Gilead, the world's biggest biotechnology company, faces…

news

Big Pharma is creeping back into development of new antibiotics after decades of largely ignoring the business due to the scant rewards offered by such medications. With the planet on the brink of losing its miracle cures for bacterial diseases, research incentives from governments are spurring drugmakers to renew efforts…

news

Drug firm Suven Life Sciences has been granted a patent from Europe and two product patents from Eurasia for a drug used in the treatment of neuro-degenerative diseases. In a BSE filing today, Suven Life said it has been granted "one product patent from Europe and two product patents from…

news

Norgine B.V. today announced that it has completed the divestment of its MENA operations and product rights for MOVICOL®, MOVIPREP®, KLEAN-PREP® and NORMACOL® in MENA to Acino. Peter Stein, CEO at Norgine said: “The divestment of Norgine’s MENA operations and product rights to Acino ensures that patients in the region…

news

Prasco Laboratories announced that it has entered into agreements with Teva Pharmaceutical Industries Ltd. (Teva) and Shire LLC, an indirect subsidiary of Shire plc, to acquire the rights to distribute Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of a Single-Entity Amphetamine Product) Extended Release Capsules,…

news

Jiangsu Lianhuan Pharmaceutical Co., Ltd. Says its unit receives approval for its seven drug production lines including hydrocortisone, from U.S Food and Drug Administration. Says the unit will be able to sell its drugs in the United States after receiving the FDA approval.   Source : reuters.com

news

Neuroderm Announces Nd0612h Achieves Comparable Pharmacokinetics To Duodopa In Head. To-Head pilot pk comparison trial. Says plans to pursue regulatory development of nd0612h in european union (eu) based on pk similarity. Says ld plasma concentrations of nd0612h in this study are in line with ld levels obtained in previous nd0612h…

news

AstraZeneca announced that the European Commission (EC) has granted marketing authorisation for Zavicefta (ceftazidime-avibactam, previously known as CAZ AVI), a new combination antibiotic for the treatment of patients with serious Gram-negative bacterial infections requiring hospitalisation. The approval includes intravenous use of Zavicefta for the treatment of adult patients suffering from…

news

Indonesian lawmakers on Monday urged authorities to seize from hospitals and health clinics all vaccines made by unapproved manufacturers, after police exposed a syndicate selling fake child vaccines for more than a decade. In a country where counterfeit drugs are widespread, the case deals a blow to government health regulators…

news

Regulus Therapeutics Inc said the U.S. Food and Drug Administration placed on clinical hold the company's drug to treat chronic hepatitis C virus infection, sending its shares plunging 60 percent in extended trading. The FDA initiated the clinical hold on the drug, RG-101, after Regulus reported a second serious adverse…